Market revenue in 2023 | USD 1,906.7 million |
Market revenue in 2030 | USD 5,096.8 million |
Growth rate | 15.1% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 32.04% in 2023. Horizon Databook has segmented the Canada genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
The country’s strong healthcare system, ample natural resources, regulated food sectors, and diverse ecosystems have positioned the country as a leader in genomics technologies. The Canadian Institutes of Health Research has undertaken a Personalized Medicine Initiative to support translation, validation, and discovery of targets, genomic signatures, & biomarkers, which can be used for disease & risk prevention.
Such initiatives are anticipated to drive the genomics market in the region. Moreover, increase in R&D in biotechnology due to growing funding by government organizations has led to increased demand for genomics, thus boosting the market share.
In 2018, Genome Canada, a nonprofit organization funded by the Canadian government, announced its collaboration with various Canadian provinces and organizations to invest a total of USD 204.4 million in two initiatives related to the advancement of genomic technology and precision medicine.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada genomics market , including forecasts for subscribers. This country databook contains high-level insights into Canada genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account